Thermo Fisher Scientific offers preview of the world’s first fully integrated LC-MS/MS Clinical Analyser

Following the presentation to the European market at EuroMedLab in Athens and to the US market at AACC 2017 of the Thermo Scientific Cascadion SM Clinical Analyser bringing together the ease of use of clinical analysers with the selectivity and sensitivity of liquid chromatography-tandem mass spectrometry (LC-MS/MS), the company will now seek CE marking  followed by FDA approval.
“This is a marvelous development, and it is really quite outstanding. It will fulfill the needs of many laboratories,” said Professor Brian Keevil, consultant clinical scientist and head of the Clinical Biochemistry Department, University Hospital of South Manchester NHS Foundation Trust, UK, after viewing a demonstration during EuroMedLab 2017.
The Cascadion system was designed and built using Thermo Fisher products and technologies combined with its industry-leading expertise in mass spectrometry.  Featuring turnkey operation, the Cascadion analyser is designed to be used by laboratory staff with no specialized training.
James Nichols, PhD, medical director, Chemistry and Point of Care Testing, Vanderbilt University Medical Center, added, “For much of what we do in terms of chromatography and mass spectrometry, we need very highly skilled and experienced medical technologists. The Cascadion analyser is relatively maintenance-free and because it includes specially designed reagent kits, there is not a lot of interaction required with the technology.”
After previewing the Cascadion analyser, Michael Vogeser, senior physician and professor of laboratory medicine, University Hospital of Munich, stated “About 70% of all physician’s decisions are based on laboratory tests so the impact on laboratory testing is huge and this completely new technological approach is of enormous value to mankind.”

www.thermofisher.com/Cascadion